David J. Greenblatt

发表

The Influence of Obesity on the Pharmacokinetics of Oral Alprazolam and Triazolam

D. Greenblatt, R. Shader, D. Abernethy, 1984, Clinical pharmacokinetics.

Influence of Oral Contraceptive Use and Cigarette Smoking, Alone and Together, on Antipyrine Pharmacokinetics

D. Greenblatt, J. Harmatz, R. Shader, 1997, Journal of clinical pharmacology.

Doxylamine and Diphenhydramine Pharmacokinetics in Women on Low‐Dose Estrogen Oral Contraceptives

David J. Greenblatt, B. Luna, Joseph M. Scavone, 1989, Journal of clinical pharmacology.

Antipyrine Pharmacokinetics in Women Receiving Conjugated Estrogens

D. Greenblatt, J. Scavone, G. Blyden, 1988, Journal of clinical pharmacology.

Inhibition of 2‐methoxyestradiol glucuronidation by probenecid

Yanli Zhao, J. Castellot, Ahmad A Sherbini, 2015, The Journal of pharmacy and pharmacology.

Effect of a herbal extract containing curcumin and piperine on midazolam, flurbiprofen and paracetamol (acetaminophen) pharmacokinetics in healthy volunteers

D. Greenblatt, J. Harmatz, V. Badmaev, 2013, British journal of clinical pharmacology.

Studies With Stable Isotopes II: Phenobarbital Pharmacokinetics During Monotherapy

J. E. Evans, D. Greenblatt, T. Browne, 1985, Journal of clinical pharmacology.

Chlordiazepoxide and oxazepam disposition in cirrhosis

D. Greenblatt, C. Naranjo, E. Sellers, 1979, Clinical pharmacology and therapeutics.

Mechanism of cytochrome P450‐3A inhibition by ketoconazole

Karthik Venkatakrishnan, David J Greenblatt, D. Greenblatt, 2011, The Journal of pharmacy and pharmacology.

Midazolam: Pharmacology and Uses

J G Reves, D J Greenblatt, D. Greenblatt, 1985, Anesthesiology.

Midazolam Pharmacodynamics and Pharmacokinetics during Acute Hypovolemia

D. Greenblatt, J. Reves, E. Bradley, 1985, Anesthesiology.

Effect of Age, Gender, and Obesity on Midazolam Kinetics

D. Greenblatt, J. Harmatz, R. Shader, 1984, Anesthesiology.

Clinical Pharmacokinetics of Quinidine

D. Greenblatt, H. Ochs, E. Woo, 1980, Clinical pharmacokinetics.

Kinetics and dynamics of lorazepam during and after continuous intravenous infusion

B L Ehrenberg, J S Harmatz, D J Greenblatt, 2000, Critical care medicine.

Mechanisms and Consequences of Drug‐Drug Interactions

D. Greenblatt, David J. Greenblatt, 2017, Clinical pharmacology in drug development.

D. Greenblatt, H. Ochs, G. Bodem, 1982, Clinical pharmacokinetics.

Reduced Systemic Absorption of Intrabronchial Lidocaine by High‐Frequency Nebulization

D. Greenblatt, H. Ochs, J. Scavone, 1990, Journal of clinical pharmacology.

Liquid chromatographic retention of β‐adrenoceptor antagonists: an index of lipid solubility 2

D. Greenblatt, R. Arendt, David J. Greenblatt, 1984 .

Evidence for regulation of UDP‐glucuronosyltransferase (UGT) 1A1 protein expression and activity via DNA methylation in healthy human livers

C. Guillemette, D. Greenblatt, U. Yasar, 2013, The Journal of pharmacy and pharmacology.

Systemic pharmacokinetics and cerebrospinal fluid uptake of intravenous ceftriaxone in patients with amyotrophic lateral sclerosis

A. Pestronk, D. Schoenfeld, D. Greenblatt, 2014, Journal of clinical pharmacology.

Differential effects of chronic lorazepam and alprazolam on benzodiazepine binding and GABAA‐receptor function

D. Greenblatt, R. Shader, W. Galpern, 1990, British journal of pharmacology.

Benzodiazepine receptor binding: Influence of physiologic and pharmacologic factors

D. Greenblatt, R. Shader, L. G. Miller, 1987, Biopharmaceutics & drug disposition.

Estimation of the Elimination Half‐Life of a Drug at Any Serum Concentration When the Km and Vmax of the Drug Are Known: Calculations and Validation With Phenytoin

J. E. Evans, T. Browne, G. Szabo, 1987, Journal of clinical pharmacology.

Cyclosporine Blood Concentrations Determined by Specific Versus Nonspecific Assay Methods

M. Kaplan, D. Greenblatt, G. Blyden, 1986, Journal of clinical pharmacology.

Volume of distribution – Again

David J. Greenblatt, 2014, Clinical pharmacology in drug development.

Alterations in Pharmacodynamics of Anxiolytics in Abstinent Alcoholic Men: Subjective Responses, Abuse Liability, and Electroencephalographic Effects of Alprazolam, Diazepam, and Buspirone

D. Ciraulo, C. Knapp, D. Greenblatt, 1997, Journal of clinical pharmacology.

Caffeine‐induced behavioural stimulation is dose‐ and concentration‐dependent

D J Greenblatt, G. Kaplan, D. Greenblatt, 1990, British journal of pharmacology.

A Large‐Sample Study of Diazepam Pharmacokinetics

D. Greenblatt, J. Harmatz, R. Shader, 1989, Therapeutic drug monitoring.

Vancomycin therapy in patients with impaired renal function: a nomogram for dosage.

D J Greenblatt, D. Greenblatt, D. Krogstad, 1981, Annals of internal medicine.

Pharmacokinetics of vancomycin in normal subjects and in patients with reduced renal function.

D. Greenblatt, D. Krogstad, R. Moellering, 1981, Reviews of infectious diseases.